Cargando…

Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer

Despite advances in the development of highly effective androgen receptor (AR)-directed therapies for the treatment of men with advanced prostate cancer, acquired resistance to such therapies frequently ensues. A significant subset of patients with resistant disease develop AR-negative tumors that l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brady, Nicholas J., Bagadion, Alyssa M., Singh, Richa, Conteduca, Vincenza, Van Emmenis, Lucie, Arceci, Elisa, Pakula, Hubert, Carelli, Ryan, Khani, Francesca, Bakht, Martin, Sigouros, Michael, Bareja, Rohan, Sboner, Andrea, Elemento, Olivier, Tagawa, Scott, Nanus, David M., Loda, Massimo, Beltran, Himisha, Robinson, Brian, Rickman, David S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185096/ https://www.ncbi.nlm.nih.gov/pubmed/34099734 http://dx.doi.org/10.1038/s41467-021-23780-y

Ejemplares similares

Evolution of structural rearrangements in prostate cancer intracranial metastases
por: Khani, Francesca, et al.
Publicado: (2023)

Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases
por: Khani, Francesca, et al.
Publicado: (2023)

Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage
por: Gjyrezi, Ada, et al.
Publicado: (2021)

Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology
por: Beg, Shaham, et al.
Publicado: (2020)

Patient derived organoids to model rare prostate cancer phenotypes
por: Puca, Loredana, et al.
Publicado: (2018)

Epigenetics in prostate cancer: clinical implications
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma
por: Musselman, Kelsey, et al.
Publicado: (2019)

Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors
por: Shohdy, Kyrillus S., et al.
Publicado: (2021)

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
por: Robinson, Brian D., et al.
Publicado: (2019)

The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy
por: van der Mijn, Johannes C., et al.
Publicado: (2022)

Distinct mesenchymal cell states mediate prostate cancer progression
por: Pakula, Hubert, et al.
Publicado: (2023)

Divergent clonal evolution of castration resistant neuroendocrine prostate cancer
por: Beltran, Himisha, et al.
Publicado: (2016)

Common germline-somatic variant interactions in advanced urothelial cancer
por: Vosoughi, Aram, et al.
Publicado: (2020)

Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer
por: Che, Meixia, et al.
Publicado: (2021)

Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide
por: Gurioli, Giorgia, et al.
Publicado: (2020)

Primary Squamous Cell Carcinoma of the Urinary Bladder Presenting as Peritoneal Carcinomatosis
por: Beltran, Himisha, et al.
Publicado: (2010)

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer
por: Kim, Seaho, et al.
Publicado: (2022)

The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in Oncology
por: Morash, Margaret, et al.
Publicado: (2018)

Validation of a Circulating Tumor DNA‐Based Next‐Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing
por: Al Zoughbi, Wael, et al.
Publicado: (2021)

ERG induces taxane resistance in castration-resistant prostate cancer
por: Galletti, Giuseppe, et al.
Publicado: (2014)

The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
por: Van Emmenis, Lucie, et al.
Publicado: (2023)

CD38 is methylated in prostate cancer and regulates extracellular NAD(+)
por: Mottahedeh, Jack, et al.
Publicado: (2018)

Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib
por: Beltran, Himisha, et al.
Publicado: (2014)

Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
por: Hopkins, Benjamin D., et al.
Publicado: (2018)

A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland
por: Pakula, Hubert, et al.
Publicado: (2017)

Loss of an Androgen-Inactivating and Isoform-Specific HSD17B4 Splice Form Enables Emergence of Castration-Resistant Prostate Cancer
por: Ko, Hyun-Kyung, et al.
Publicado: (2018)

CATCH-KB: Establishing a Pharmacogenomics Variant Repository for Chemotherapy-Induced Cardiotoxicity
por: Morash, Maggie, et al.
Publicado: (2018)

Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
por: Tiwari, Ritika, et al.
Publicado: (2020)

Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia
por: Sugita, Mayumi, et al.
Publicado: (2021)

Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer
por: Salvi, Samanta, et al.
Publicado: (2016)

Whole-genome characterization of myoepithelial carcinomas of the soft tissue
por: Cyrta, Joanna, et al.
Publicado: (2022)

Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
por: Pisapia, David J., et al.
Publicado: (2020)

Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors
por: Rajappa, Prajwal, et al.
Publicado: (2022)

SAT-339 Cross-Talk with Breast Adipose Tissue Contributes to Obesity-induced DNA Damage in BRCA Mutant Breast Epithelial Cells
por: Bhardwaj, Priya, et al.
Publicado: (2019)

A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents
por: Wilkes, David C., et al.
Publicado: (2017)

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
por: Auguste, Aurélie, et al.
Publicado: (2020)

Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
por: Conteduca, Vincenza, et al.
Publicado: (2018)

Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay
por: Orlando, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vpvhrh6j7h8dehib01kcfu83t4